Freenome

What Freenome does

Freenome is a biotechnology company working on blood-based cancer screening. Its research combines molecular measurements, machine learning and clinical studies to develop screening tests for different cancer types. The company also develops digital systems to support screening workflows and evidence collection. Freenome became publicly traded on Nasdaq in July 2026 following its business combination with Perceptive Capital Solutions Corp.